NASDAQ Equity Snapshot
MENS Weekly Equity Report
Jyong Biotech Ltd. Ordinary Shares
What the company does
Jyong Biotech Ltd. (ticker: MENS) is a pioneering biotechnology firm focused on developing advanced therapeutic solutions for cancer and autoimmune diseases. The company leverages its expertise in genomics and molecular biology to cultivate a diverse pipeline of innovative treatments, supported by a compelling intellectual property portfolio. Through strategic collaborations within the biopharmaceutical sector, Jyong Biotech is well-positioned to capitalize on emerging market opportunities while prioritizing scientific rigor and patient-centric approaches, establishing itself as a key player in the evolution of healthcare innovation.
What the weekly tape is saying
MENS closed the latest completed week at 1.58 USD. The 4-week return is -21.4% and the 12-week return is -7.1%. Trend Signal is inactive, Market Dynamics is 0.23. Setup signature: Risk-first tape with a 28/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 5.78 USD
- Vs Trend Line
- -72.7%
- Fair Value
- 19.99 USD
- Vs Fair Value
- -92.1%
- 52W High
- 67.00 USD
- 52W Low
- 1.43 USD
- Drawdown
- -97.6%
- Range Position
- 0.2%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- US Healthcare
- Sector Rank
- 1017 of 1038
- Sector Percentile
- 2.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.23
- 4W MD Change
- 11.0%
- Relative Strength
- -
- 4W RS Change
- -
- Expectation
- Undecided
- Probability
- 45.53%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 787.5K
- 13W Average
- 533.7K
- 52W Average
- 1.9M
- Vs 13W
- 1.5x
- Vs 52W
- 0.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 12.0%
- 52W Volatility
- 27.4%
- Upside Weeks
- 25
- Downside Weeks
- 25
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 17.1% / -15.3%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 171.1M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1.58 USD | -21.8% | 5.78 USD | 19.99 USD | 0.23 | - | 787.5K | Off |
| 5 Jun 2026 | 2.02 USD | -8.2% | 7.00 USD | 20.35 USD | 0.29 | - | 367.2K | Off |
| 29 May 2026 | 2.20 USD | 2.3% | 8.23 USD | 20.73 USD | 0.29 | - | 166.3K | Off |
| 22 May 2026 | 2.15 USD | 7.0% | 9.65 USD | 21.11 USD | 0.25 | - | 249.9K | Off |
| 15 May 2026 | 2.01 USD | -2.0% | 11.60 USD | 21.52 USD | 0.21 | - | 219.0K | Off |
| 8 May 2026 | 2.05 USD | -8.9% | 13.50 USD | 21.94 USD | 0.17 | - | 365.1K | Off |
| 1 May 2026 | 2.25 USD | 2.7% | 15.28 USD | 22.38 USD | 0.14 | - | 247.1K | Off |
| 24 Apr 2026 | 2.19 USD | -10.2% | 16.80 USD | 22.84 USD | 0.13 | - | 406.3K | Off |
| 17 Apr 2026 | 2.44 USD | -2.0% | 18.72 USD | 23.32 USD | 0.15 | - | 714.5K | Off |
| 10 Apr 2026 | 2.49 USD | 1.6% | 20.83 USD | 23.82 USD | 0.05 | - | 530.9K | Off |
| 2 Apr 2026 | 2.45 USD | 26.3% | 22.79 USD | 24.34 USD | -0.12 | - | 828.0K | Off |
| 27 Mar 2026 | 1.94 USD | 14.1% | 24.46 USD | 24.89 USD | -0.32 | - | 719.6K | Off |
| 20 Mar 2026 | 1.70 USD | -14.1% | 26.22 USD | 25.48 USD | -0.59 | - | 1.3M | Off |
| 13 Mar 2026 | 1.98 USD | -8.3% | 27.69 USD | 26.10 USD | -0.82 | - | 979.5K | Off |